Molecular diagnostic services
搜索文档
Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?
ZACKS· 2026-10-22 01:11
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Veracyte (VCYT) , which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider. When looking at the last two reports, this molecular diagnostic company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 39.26%, on average, in the last two quarters. For the most recent ...